Trial Profile
Retrospective Data Collection Study in Patients Receiving Two or More OZURDEX Injections for Macular Oedema Secondary to Retinal Vein Occlusion
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 09 May 2019
Price :
$35
*
At a glance
- Drugs Dexamethasone (Primary)
- Indications Retinal vein occlusion
- Focus Therapeutic Use
- Sponsors Allergan
- 14 Apr 2015 New trial record